Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

The Light of Psychedelics in a Dark World

Screenshot 2024-06-27 at 11.57.10 AM

The Light of Psychedelics in a Dark World

38 years after founding the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) on April 8, 1986, Rick Doblin, Ph.D., will explore nearly four decades of psychedelic triumphs and challenges. In December 2023, Lykos Therapeutics (formerly MAPS Public Benefit Corporation) submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for MDMA-assisted therapy for posttraumatic stress disorder (PTSD). Rick will discuss MAPS’ path toward mass mental health by means of public education, drug policy reform, and global humanitarian projects.

Share: The Light of Psychedelics in a Dark World


Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.